Mary-Claire King and a team of researchers at UC Berkeley developed a statistical model to identify hereditary risk for breast cancer [1].
This development marks a significant shift in how medical professionals approach hereditary diseases. By pinpointing genetic markers, doctors can potentially identify high-risk patients earlier and implement life-saving interventions before a disease manifests.
The research process spanned 17 years [1]. To build the model, King and her team conducted interviews with thousands of women [1]. Half of those interviewed were breast-cancer patients [1]. This extensive data collection allowed the team to test the theory that specific genetic markers are linked to the hereditary transmission of the disease.
King said, "After analyzing interviews with thousands of women—half of them breast-cancer patients—her team developed a statistical model that supported her theory..." [1].
The study focused on the intersection of family history and genetic predisposition. By analyzing the patterns found in the interview data, the Berkeley team sought to create a reliable method for predicting who is most susceptible to the condition based on their lineage [1].
While the model provides a roadmap for identification, the research also highlights the complexities of genetic testing. The ability to predict future illness introduces difficult decisions regarding when to test children, and how to manage the psychological impact of knowing a hereditary risk exists [1].
“The research process spanned 17 years.”
The transition from observational family history to a statistical genetic model allows for more precise preventative medicine. However, it also creates a new ethical dilemma for families regarding the age of testing and the right of a child to not know their genetic destiny.
